Skip to main content
. 2022 Apr 8;12(4):683–691. doi: 10.1016/j.jpha.2022.04.002

Fig. 3.

Fig. 3

The inhibitory effects of 17 constituents (100 μM, final concentration) in ERC against hPL. All data are shown as means ± SD (n = 2). ∗P < 0.0001 versus the control group. PGG: 1,2,3,4,6-penta-O-galloyl-β-d-glucopyranose.